Pleural effusion as a substitute for tumor tissue in detecting EGFR/ALK mutations in non-small cell lung cancer-Reference-Cited by-同舟云学术

Pleural effusion as a substitute for tumor tissue in detecting EGFR/ALK mutations in non-small cell lung cancer

Published:2019-05 Issue:18 Volume:98 Page:e15450
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Pang Caishuang,Ma Huiwen,Qin Jiangyue,Wang Sixiong,Wan Chun,Yang Ting,Shen Yongchun,Wang Donglin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference43 articles.

1. Lung cancer: understanding its molecular pathology and the 2015 WHO clasification;Inamura;Front Oncol,2017

2. Cancer statistics, 2017;Siegel;A Cancer J Clin,2017

3. Treatment choice in EGFR-mutant non-small-cell lung cancer;Brueckl;Lancet Oncol,2017

4. Lung cancer: current therapies and new targeted treatments;Hirsch;Lancet,2017

5. Gefitinib or erlotinib vs chemotherapy for egfr mutation-positive lung cancer: individual patient data meta-analysis of overall survival;Lee;J Natl Cancer Inst,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimally Invasive, Maximally Effective;Surgical Pathology Clinics;2024-09

2. Malignant pleural effusions for cancer genotyping: A matter of trans-pleural traffic of cell-free tumor DNA;Molecular and Cellular Probes;2022-02

3. Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients;Current Oncology;2021-12-24

4. The prevalence of tumour markers in malignant pleural effusions associated with primary pulmonary adenocarcinoma: a retrospective study;European Clinical Respiratory Journal;2021-01-01

5. Evaluation of liquid based cytology in detection of EGFR mutation in NSCLC by large samples;Journal of Thoracic Disease;2020-09